doi: 10.1016/0090-4295(75)90704-9.
Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment
- PMID: 1145932
- DOI: 10.1016/0090-4295(75)90704-9
Item in Clipboard
Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment
Urology.
1975 Aug.
Abstract
Twenty-six patients with advanced prostatic carcinoma refractory to conventional endocrine treatment were treated with a new oral nonsteriodal antiandrogen, flutamide. There were 6 responders and 20 failures. No serious toxicity attributable to flutamide was observed.
Similar articles
-
Experience with flutamide in previously untreated patients with advanced prostatic cancer.J Urol. 1979 Nov;122(5):640-3. doi: 10.1016/s0022-5347(17)56539-8. J Urol. 1979. PMID: 501817
-
Flutamide therapy for advanced prostatic cancer: a phase II study.Br J Urol. 1985 Apr;57(2):172-4. doi: 10.1111/j.1464-410x.1985.tb06415.x. Br J Urol. 1985. PMID: 3986452
-
Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.Cancer. 1984 Aug 15;54(4):744-50. doi: 10.1002/1097-0142(1984)54:4<744::aid-cncr2820540426>3.0.co;2-p. Cancer. 1984. PMID: 6378356 Clinical Trial.
-
Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.Cancer Treat Res. 1988;39:131-45. doi: 10.1007/978-1-4613-1731-9_9. Cancer Treat Res. 1988. PMID: 2908604 Review.
-
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.Prog Clin Biol Res. 1989;303:161-7. Prog Clin Biol Res. 1989. PMID: 2674982 Review. No abstract available.
Cited by
-
Identification of PRDX5 as A Target for The Treatment of Castration-Resistant Prostate Cancer.Adv Sci (Weinh). 2024 Mar;11(9):e2304939. doi: 10.1002/advs.202304939. Epub 2023 Dec 20. Adv Sci (Weinh). 2024. PMID: 38115765 Free PMC article.
-
Androgen receptor inhibitors in treating prostate cancer.Asian J Androl. 2025 Mar 1;27(2):144-155. doi: 10.4103/aja202494. Epub 2024 Nov 19. Asian J Androl. 2025. PMID: 39558858 Free PMC article. Review.
-
Genitourinary tumors.J Surg Oncol. 2022 Oct;126(5):926-932. doi: 10.1002/jso.27031. J Surg Oncol. 2022. PMID: 36087085 Free PMC article. Review.
-
Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer.Drugs. 1989 Aug;38(2):185-203. doi: 10.2165/00003495-198938020-00003. Drugs. 1989. PMID: 2670515 Review.
-
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on.Cancers (Basel). 2021 Jan 29;13(3):509. doi: 10.3390/cancers13030509. Cancers (Basel). 2021. PMID: 33572755 Free PMC article. Review.